Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2004 4
2005 1
2006 2
2007 3
2012 2
2013 2
2014 1
2015 4
2016 1
2018 1
2019 2
2020 3
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Differential Diagnosis of Central Neurocytoma: Two Cases.
Steinsiepe VK, Frick H, Jochum W, Fournier JY. Steinsiepe VK, et al. J Neurol Surg A Cent Eur Neurosurg. 2021 Nov;82(6):599-603. doi: 10.1055/s-0040-1718693. Epub 2020 Dec 22. J Neurol Surg A Cent Eur Neurosurg. 2021. PMID: 33352608
Central neurocytoma are rare primary brain tumors of the young and middle-aged adult, typically located in the lateral ventricles. Diagnosis has historically been difficult due to histomorphologic similarities to oligodendroglioma and ependymal tumors and remains a challen …
Central neurocytoma are rare primary brain tumors of the young and middle-aged adult, typically located in the lateral ventricles. Di …
The role of chemotherapy in the treatment of central neurocytoma.
Johnson MO, Kirkpatrick JP, Patel MP, Desjardins A, Randazzo DM, Friedman HS, Ashley DM, Peters KB. Johnson MO, et al. CNS Oncol. 2019 Nov 1;8(3):CNS41. doi: 10.2217/cns-2019-0012. Epub 2019 Nov 5. CNS Oncol. 2019. PMID: 31686534 Free PMC article. Review.
Aim: Central neurocytoma (CN) is a rare WHO grade II central nervous system (CNS) tumor. ...
Aim: Central neurocytoma (CN) is a rare WHO grade II central nervous system (CNS) tumor. ...
The management of residual or recurrent central neurocytoma.
Thawani JP, Lee JY. Thawani JP, et al. Neurosurg Clin N Am. 2015 Jan;26(1):67-81. doi: 10.1016/j.nec.2014.09.002. Neurosurg Clin N Am. 2015. PMID: 25432185 Review.
Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative activity demonstrated, the extent of surgical resection, the neuroanatomic location and accessibility of residual tumor, and the patient's po …
Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative a …
The management of central neurocytoma: radiosurgery.
Monaco EA 3rd, Niranjan A, Lunsford LD. Monaco EA 3rd, et al. Neurosurg Clin N Am. 2015 Jan;26(1):37-44. doi: 10.1016/j.nec.2014.09.008. Epub 2014 Oct 18. Neurosurg Clin N Am. 2015. PMID: 25432182 Review.
Central neurocytomas are rare, usually benign, intraventricular tumors that can be challenging to completely resect and often recur. Adjuvant therapy has been suggested for residual or recurrent tumors, especially in the setting of atypical neurocytomas. The limited data a …
Central neurocytomas are rare, usually benign, intraventricular tumors that can be challenging to completely resect and often recur. Adjuvan …
Clinical outcome and quality of life after treatment of patients with central neurocytoma.
Kim CY, Kim DG, Joo JD, Kim YH. Kim CY, et al. Neurosurg Clin N Am. 2015 Jan;26(1):83-90. doi: 10.1016/j.nec.2014.09.007. Neurosurg Clin N Am. 2015. PMID: 25432186 Review.
Central neurocytoma (CN) is an uncommon, deep-seated tumor of the central nervous system. ...
Central neurocytoma (CN) is an uncommon, deep-seated tumor of the central nervous system. ...
Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma.
Patel DM, Schmidt RF, Liu JK. Patel DM, et al. J Clin Neurosci. 2013 Sep;20(9):1193-9. doi: 10.1016/j.jocn.2013.01.001. Epub 2013 Jun 27. J Clin Neurosci. 2013. PMID: 23810386 Review.
We present a comprehensive review of these rare tumors, including their epidemiology, clinical presentation, radiological presentation, histopathological findings, and options for intervention including surgery, radiation therapy, stereotactic radiosurgery, and chemotherap …
We present a comprehensive review of these rare tumors, including their epidemiology, clinical presentation, radiological presentation, hist …
Treatment recommendations for the various subgroups of neurocytomas.
Rades D, Schild SE. Rades D, et al. J Neurooncol. 2006 May;77(3):305-9. doi: 10.1007/s11060-005-9047-3. Epub 2006 Mar 31. J Neurooncol. 2006. PMID: 16575540 Review.
This study was performed to determine the best available treatment for typical and atypical neurocytomas (MIB-1 labeling index >3%, atypical histology) in various age groups ( 18 years). The data of all neurocytoma patients reported since 1982, when …
This study was performed to determine the best available treatment for typical and atypical neurocytomas (MIB-1 labeling index >3%, atypi …
Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience.
Byun J, Hong SH, Yoon MJ, Kwon SM, Cho YH, Kim JH, Kim CJ. Byun J, et al. J Neurooncol. 2018 Dec;140(3):669-677. doi: 10.1007/s11060-018-2997-z. Epub 2018 Sep 17. J Neurooncol. 2018. PMID: 30225773
INTRODUCTION: Central neurocytoma (CN) is a very rare neuronal neoplasm. The clinical implications of the potential prognostic factors for these lesions, including tumor atypia, have therefore not been clarified. ...The use of STR plus RT or RS may be a viable treatment st …
INTRODUCTION: Central neurocytoma (CN) is a very rare neuronal neoplasm. The clinical implications of the potential prognostic factor …
Treatment of atypical neurocytomas.
Rades D, Fehlauer F, Schild SE. Rades D, et al. Cancer. 2004 Feb 15;100(4):814-7. doi: 10.1002/cncr.20032. Cancer. 2004. PMID: 14770439 Free article. Review.
The objective of this analysis was to define the optimal treatment for patients with these atypical tumors. METHODS: The first atypical neurocytoma was described in 1989. The patients reported since then were reviewed for age, gender, extent of resection, MIB-1 index, hist …
The objective of this analysis was to define the optimal treatment for patients with these atypical tumors. METHODS: The first atypical n …
26 results